Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Annales D'Endocrinologie|June 13, 2024
LipomatosesHippolyte Dupuis, Madleen Lemaitre, Arnaud Jannin, et al.European Thyroid Journal|May 27, 2022
Unexpected cure of a toxic nodule in a multinodular goiter induced by immune checkpoint inhibitors: a case reportHippolyte Dupuis, Emilie Merlen, Arnaud Jannin, et al.Frontiers in Endocrinology|May 24, 2021
Phakomatoses and Endocrine Gland Tumors: Noteworthy and (Not so) Rare AssociationsBenjamin Chevalier, Hippolyte Dupuis, Arnaud Jannin, et al.Diabetes & Metabolism|April 29, 2026
Bone phenotype in familial partial lipodystrophy type 2: insulin resistance and sclerostinHippolyte DupuiS, Arnaud Jannin, Lucille Van Es, et al.Clinical Chemistry and Laboratory Medicine|July 10, 2025
Performance of afternoon (16:00 h) serum cortisol for the diagnosis of Cushing's syndromeHippolyte Dupuis, Emilie Merlen, Julien Elices-Diez, et al.Journal of the Endocrine Society|July 6, 2023
Prevalence of Endocrine Manifestations and GIST in 108 Systematically Screened Patients With Neurofibromatosis Type 1Hippolyte Dupuis, Benjamin Chevalier, Catherine Cardot-Bauters, et al.Diabetes, Obesity & Metabolism|January 20, 2025
Safety and effectiveness in an uncontrolled setting of glucagon-like-peptide-1 receptor agonists in patients with familial partial lipodystrophy: Real-life experience from a national reference networkSophie Lamothe, Ines Belalem, Marie-Christine Vantyghem, et al.Diabetes, Obesity & Metabolism|August 6, 2026
Glycemic and Renal Effects of SGLT2 Inhibitors in Monogenic Diabetes: A Real-World National StudyEstelle Audrain, Pierre Bel Lassen, Christine Bellanné-Chantelot, et al.Pageof 1